NuScale Power's European Modular Reactor Project: A Step Forward with Challenges
Money

NuScale Power's European Modular Reactor Project: A Step Forward with Challenges

authorBy T. Harv Eker
DateMar 10, 2026
Read time2 min

NuScale Power has announced a pivotal development: its small modular reactors (SMRs) are set to be deployed in Europe's inaugural SMR-powered nuclear facility. This project, spearheaded by the Romanian energy firm RoPower, represents a substantial stride for NuScale, whose primary revenue streams have historically stemmed from consulting services provided to entities like Fluor, a construction firm collaborating with RoPower.

Despite this promising advancement, the journey for NuScale is far from complete. While RoPower's decision to proceed with the plant is a positive signal, the critical next step involves securing the necessary financial backing for construction. This funding acquisition process could extend for several months, and without it, NuScale's involvement remains tenuous. The company's business model hinges on successful SMR deployment, and its capacity to mass-produce and deliver these reactors remains untested. Although NuScale reported considerable liquidity at the close of 2025, the primary concern now shifts to its ability to execute this ambitious project.

Ultimately, NuScale Power's path to broader commercial success is contingent upon the successful delivery and operation of this first SMR. Proving the viability and efficiency of its technology through this project is paramount to attracting future clients and scaling its operations. Until then, NuScale is viewed as a company with innovative concepts yet to be fully realized. Therefore, this investment opportunity is best suited for those with a higher risk tolerance and a long-term perspective on emerging energy technologies.

This initiative underscores a global movement towards sustainable and innovative energy solutions. The success of this project could pave the way for a new era in nuclear power, emphasizing efficiency and modularity. Such endeavors are crucial for transitioning to a cleaner energy future, fostering technological advancements, and promoting international collaboration in addressing energy demands responsibly.

More Articles
Amprius Technologies (AMPX) Financial Performance and Analyst Outlook
Amprius Technologies (AMPX) recently released its latest earnings report, showing substantial growth in revenue and a reduction in net loss for both the fourth quarter and the full fiscal year 2025. Following this positive report, B. Riley raised its price target for AMPX shares, maintaining a 'Buy' rating. The company also announced a strategic partnership to enhance its battery production capabilities in the US.
By Scott PapeMar 10, 2026
Needham Revises Archer Aviation's Price Target to $9
Needham & Company has adjusted its price target for Archer Aviation Inc. (ACHR) from $10 to $9, while reaffirming a Buy rating. This change follows Archer's strong fourth-quarter performance, which highlighted a robust financial position with $2.0 billion in liquidity and ongoing advancements in its Midnight aircraft program, including vertical take-off and landing flight tests and preparation for piloted operations within the eVTOL Integration Pilot Program.
By Mr. Money MustacheMar 10, 2026
CFTC Chair Declares US as 'Crypto Capital,' Unveils New Guidance
CFTC Chairman Michael Selig has proclaimed the United States as the "crypto capital of the world," introducing new guidelines for non-custodial software developers, a crypto asset taxonomy, and Project Crypto to resolve inter-agency conflicts. He also criticized Dodd-Frank's impact and promoted prediction markets, crediting former President Trump for fostering a crypto-friendly environment.
By Scott PapeMar 10, 2026
Analyst Firms Adjust Price Targets for BigBear.ai Amidst Q4 Performance and Future Outlook
Cantor Fitzgerald and H.C. Wainwright have revised their price targets for BigBear.ai Holdings, Inc. (BBAI) following its fourth-quarter earnings release. While Cantor Fitzgerald lowered its target to $5 due to a revenue decline, H.C. Wainwright maintained a 'Buy' rating, adjusting its target to $6, citing improved financial flexibility. The company reported a narrower-than-expected loss per share and highlighted strategic advancements in debt reduction, international expansion, and acquisitions, positioning itself for future growth with government AI initiatives.
By Mr. Money MustacheMar 10, 2026
NexGel to Acquire Regenerative Biomaterial Portfolio from Celularity, Projects Triple Revenue
NexGel Inc. is set to acquire a regenerative biomaterial portfolio from Celularity, Inc., a strategic move expected to nearly triple NexGel's annual revenue to approximately $35 million in 2026. This acquisition, along with significant financing, is poised to make the company immediately profitable and a more substantial player in the medical technology sector. The portfolio includes products with over a decade of clinical use, offering stable revenue and future growth prospects through additional product filings.
By Scott PapeMar 10, 2026